Long term release dose form of JAK 1 inhibitor (Exp divisional: 2016-0102)

• 收藏
• 分享

专利权人:

INCYTE CORPORATION

发明人:

YELESWARAM, Krishnaswamy,PARIKH, Bhavnish,MODI, Dilip P,SHETH, Trupti

申请号：

CR20190343

公开号：

CR20190343A

申请日:

2014.08.06

申请国别(地区):

CR

年份:

2019

代理人:

摘要：

The persistent release dosage form according to the invention includes {1 - {1 - [3-fluoro-2 - (sulfur trifluoride) isonicotine} - 4-il} - 3 - [4 - (7h pirrolo [2, 3-d] pirimidin-4-il] - 1h-pirazol-1-il] azetin-3-il} acrylonitrile or acceptable salts of the agent and related dosage and method.La presente invención se refiere a formas de dosificación de liberación prolongada que comprenden {1-{1-[3-fluoro-2-(trifluorometil)isonicotinoil]piperidin-4-il}-3-[4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il]azetidin-3-il}acetonitrilo o una sal farmacéuticamente aceptable de este y dosis y métodos relacionadas con estas.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/